Mitochondrial m.13513G>A Point Mutation in ND5 in a 16-Year-Old Man with Leber Hereditary Optic Neuropathy Detected by Next-Generation Sequencing

Abstract

This article reports a Leber hereditary optic neuropathy (LHON) case associated for the first time with mitochondrial m.13513G>A mutation. We present a 16-year-old man who complained of subacute, painless, visual loss. Ocular examination showed optic nerve atrophy, papillary pseudoedema, and optic disc pallor. Extraocular manifestations included hypertrophic myocardiopathy and myopathy. Initial genetic analysis excluded the three most common LHON mutations. Sanger sequencing of the whole mitochondrial deoxyribonucleic acid showed no mutation. Next-generation sequencing (NGS) revealed m.13513G>A mutation in the NADH dehydrogenase (ND5) subunit gene (MT-ND5). The m.13513G>A mutation has never been associated with LHON phenotype without Leigh/mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes features. NGS techniques should be considered when this diagnosis is strongly suspected.

Keywords

Leber hereditary optic neuropathy - whole genome sequencing - next-generation sequencing

• References

• 1 Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol 2010; 55 (04) 299-334
• 2 Chacón-Camacho OF, Zenteno JC. Gene therapy for vision restoration in patients with Leber congenital amaurosis (LCA) due to RPE65 gene mutations: beginning the phase IV trial [article in Spanish]. Gac Med Mex 2017; 153 (02) 276-278
• 3 Mitchell AL, Elson JL, Howell N, Taylor RW, Turnbull DM. Sequence variation in mitochondrial complex I genes: mutation or polymorphism?. J Med Genet 2006; 43 (02) 175-179
• 4 Santorelli FM, Tanji K, Kulikova R. , et al. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem Biophys Res Commun 1997; 238 (02) 326-328
• 5 Kirby DM, Boneh A, Chow CW. , et al. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease. Ann Neurol 2003; 54 (04) 473-478
• 6 Sudo A, Honzawa S, Nonaka I, Goto Y. Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan. J Hum Genet 2004; 49 (02) 92-96
• 7 Monlleo-Neila L, Toro MD, Bornstein B. , et al. Leigh syndrome and the mitochondrial m.13513G>A mutation: expanding the clinical spectrum. J Child Neurol 2013; 28 (11) 1531-1534
• 8 Wang Z, Qi XK, Yao S. , et al. Phenotypic patterns of MELAS/LS overlap syndrome associated with m.13513G>A mutation, and neuropathological findings in one autopsy case. Neuropathology 2010; 30 (06) 606-614
• 9 Blok MJ, Spruijt L, de Coo IF. et al. Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease. HJ J Med Genet 2007; 44 (04) e74
• 10 Van Karnebeek CDM, Waters PJ, Sargent MA. , et al. Expanding the clinical phenotype of the mitochondrial m.13513G>A mutation with the first report of a fatal neonatal presentation. Dev Med Child Neurol 2011; 53 (06) 565-568
• 11 Ruiter EM, Siers MH, van den Elzen C. , et al. The mitochondrial 13513G > A mutation is most frequent in Leigh syndrome combined with reduced complex I activity, optic atrophy and/or Wolff-Parkinson-White. Eur J Hum Genet 2007; 15 (02) 155-161
• 12 Brecht M, Richardson M, Taranath A, Grist S, Thorburn D, Bratkovic D. Leigh syndrome caused by the MT-ND5 m.13513G>A mutation: a case presenting with WPW-like conduction defect, cardiomyopathy, hypertension and hyponatraemia. JIMD Rep 2015; 19: 95-100
• 13 Uemura A, Osame M, Nakagawa M, Nakahara K, Sameshima M, Ohba N. Leber's hereditary optic neuropathy: mitochondrial and biochemical studies on muscle biopsies. Br J Ophthalmol 1987; 71 (07) 531-536
• 14 Duan M, Tu J, Lu Z. Recent advances in detecting mitochondrial DNA heteroplasmic variations. Molecules 2018; 23 (02) 323
• 15 Vasta V, Ng SB, Turner EH, Shendure J, Hahn SH. Next generation sequence analysis for mitochondrial disorders. Genome Med 2009; 1 (10) 100